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ABSTRACT
Chromatin disorganization is one of the major alterations linked to prelamin A 
processing impairment. In this study we demonstrate that BAF is necessary to modulate 
prelamin A effects on chromatin structure. We show that when prelamin A and BAF 
cannot properly interact no prelamin A-dependent effects on chromatin occur; similar 
to what is observed in human Nestor Guillermo Progeria Syndrome cells harboring a 
BAF mutation, in HEK293 cells expressing a BAF mutant unable to bind prelamin A, or 
in siRNA mediated BAF-depleted HEK293 cells expressing prelamin A. BAF is necessary 
to induce histone trimethyl-H3K9 as well as HP1-alpha and LAP2-alpha nuclear 
relocalization in response to prelamin A accumulation. These findings are enforced by 
electron microscopy evaluations showing how the prelamin A-BAF interaction governs 
overall chromatin organization. Finally, we demonstrate that the LAP2-alpha nuclear 
localization defect observed in HGPS cells involves the progerin-BAF interaction, thus 
establishing a functional link between BAF and prelamin A pathological forms.
INTRODUCTION
BAF is a DNA binding protein that allows DNA 
filament interconnection in vivo and condensing of longer 
DNA molecules in vitro [1]. BAF localizes ubiquitously 
in cells, and several nuclear physiological events 
including post-mitotic nuclear assembly, chromatin 
remodeling, gene expression and DNA damage repair, 
seem to depend on proper BAF cellular distribution and 
expression [2], [3]. In the nucleus, BAF directly binds 
three fundamental groups of proteins: LEM-domain 
proteins [4–7], histones [8], [9] and nuclear lamins [10], 
[5]. Lamins are components of the nuclear lamina, a 
proteinaceous meshwork underlying the inner nuclear 
membrane. This structure arises from the polymerization 
of type V intermediate filaments encoded by the LMNA 
gene, named lamin A and lamin C, which, in combination 
with lamin B, provide a molecular link between the 
inner nuclear membrane and the genome. In particular, 
it has been demonstrated that components of the nuclear 
lamina directly interact with DNA and with proteins 
able to influence the accessibility to genetic information 
[11]. Thus, it is not surprising that a wide range of rare 
diseases, collectively named laminopathies, results from 
LMNA mutations. Muscular dystrophy, cardiomyopathy, 
neuropathy, lipodystrophy and progeroid syndromes are 
overlapping disorders identified in laminopathic patients 
[12]. At the molecular level, LMNA gene mutations 
affecting prelamin A processing lead to an acceleration in 
aging, causing adipose tissue atrophy, bone resorption and 
other systemic symptoms as described in Mandibuloacral 
Dysplasia (MAD), Hutchinson-Gilford Progeria Syndrome 
(HGPS), Familiar Partial Lipodystrophy type 2 (FPLD2) 
and Restrictive Dermophathy (RD) patients [12]. 
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Prelamin A is the precursor of lamin A, and, unlike 
other types of lamins, it undergoes a specific maturation 
pathway. If maturation fails, prelamin A accumulation 
affects nuclear morphology [13], chromatin structure 
and DNA binding protein function [14–16] through a 
mechanism that is poorly understood.
We previously demonstrated in vivo molecular 
interaction between BAF and different prelamin A forms 
[17]. Prelamin A affects BAF cellular distribution inducing 
its nuclear localization; in accordance, prelamin A mutated 
forms identified in laminopathic cells have a similar 
effect [18]. Given that several chromatin modifying 
proteins have been identified among BAF binding 
partners [8], [9], [19], it is conceivable that the effects 
on chromatin organization caused by prelamin A could 
potentially depend on its interaction with BAF. The study 
reported here was aimed at demonstrating that the BAF-
prelamin A interaction is necessary to mediate prelamin 
A accumulation effects on chromatin organization. 
To this end, we took advantage of Nestor-Guillermo 
Progeria Syndrome (NGPS) skin fibroblasts induced to 
accumulate prelamin A, and HEK293 cells transfected 
with prelamin A constructs in combination with different 
BAF mutants. NGPS is a rare progeroid syndrome 
characterized by aged appearance, growth retardation 
and decreased subcutaneous fat [20]. This disease is 
due to a point mutation (c.34G > A [p.Ala12Thr]) in the 
BANF1 gene, codifying for BAF. In our experiments we 
observed that the expression of both NGPS-BAF mutant 
and a BAF mutant (BAF-G47E) unable to interact with 
the inner nuclear membrane components, affect the 
ability of prelamin A to modify chromatin organization. 
We demonstrate that the redistribution of histone H3 
trimethylated at lysine 9 (H3K9m3), of HP1-alpha, and 
of the chromatin interacting protein LAP2-alpha, induced 
by prelamin A, need a proper prelamin A-BAF interaction. 
This is also required to preserve the overall prelamin 
A-dependent chromatin reorganization. In addition, we 
demonstrate the involvement of BAF in the deleterious 
effects triggered by progerin (a truncated prelamin A form 
accumulated in HGPS cells) on LAP2-alpha, observed 
in HGPS cells. Our results demonstrate a functional 
link between prelamin A and BAF allowing for a better 
understanding of the mechanism underlying pathological 
aging. 
RESULTS
NGPS cells show dysmorphic nuclei with altered 
BAF, lamin A/C and prelamin A distribution 
which is associated with impaired prelamin 
A-mediated H3K9m3 intranuclear clustering
In accordance with previously described results [21], 
we observed that in NGPS cells the BAF-A12T mutation 
affected BAF protein level. BAF was detectable in NGPS 
nuclei but hardly visible in the cytoplasm. In control 
cells, BAF was present in both cellular compartments 
(Figure 1A). Lamin A/C staining highlighted NGPS 
nuclear morphology defects, as described [21]. Increase 
in nuclear size and/or presence of nuclear blebs were 
observed in 80% of BANF1 mutated cells (Figure 1A 
asterisk and arrow, Figure 1B) while in control cells, less 
of 20% of nuclei were dysmorphic. Lamin A/C and BAF 
staining colocalized at the nuclear lamina of control and 
NGPS cells, however NGPS nuclei were characterized by 
honeycomb labeling patterns where rarefaction of Dapi 
staining was detectable (Figure 1C arrowhead). 
In NGPS cells prelamin A processing is normal as 
demonstrated by the absence of prelamin A and progerin 
staining (Figure S1). Mevinolin addition to NGPS cells 
induced the accumulation of prelamin A at the nuclear 
lamina and at intranuclear aggregates, as observed in 
control cells. Prelamin A and BAF colocalized in control 
cells at both the nuclear periphery and the intranuclear 
aggregates (Figure 1D arrow and arrowhead, Figure 1E 
arrows). In contrast, in mevinolin-treated NGPS cells, 
though BAF nuclear recruitment was observed, BAF-
prelamin A colocalization was impaired. In particular we 
observed that colocalization at intranuclear aggregates 
was partially lost (Figure 1D–1E arrowheads) while, at 
the nuclear lamina both proteins revealed a colocalization 
characterized by honeycomb pattern (Figure 1D–1F 
arrow). 
Prelamin A accumulation in mevinolin-treated cells 
induced H3K9m3 clustering in more than 80% of control 
cells in which the intranuclear aggregates of lamin A 
precursor perfectly colocalized with H3K9m3 aggregates 
(Figure 2A–2B, 2E and 2D arrow). On the contrary, in 
NGPS cells, even if prelamin A was accumulated and 
normally distributed in the nucleus, H3k9m3 clustering 
failed (Figure 2B and 2C) and only a limited number of 
prelamin A intranuclear aggregates (50%) colocalized 
with H3k9m3 aggregates (Figure 2D arrowhead and 2E). 
However, it is important to note that in NGPS untreated 
cells, H3K9m3 was barely detectable and less than 20% 
of nuclei showed a normal clustered distribution, while in 
control cells a normal pattern was detectable in 60% of 
cells (Figure 2D and 2C). 
Prelamin A-BAF interaction is compromised by 
the BANF1 gene mutation occurring in NGPS 
cells
Since in NGPS cells prelamin A and BAF 
colocalization appears partially lost, we wondered if 
prelamin A-BAF binding could be compromised by the 
BAF-A12T mutation. To this aim, HEK293 cells were 
transfected with FLAG-tagged lamin A (LA-WT) or 
FLAG-tagged prelamin A (LA-C661M) in combination 
with three GFP-tagged BAF constructs: wild type BAF 
(BAF-WT), NGPS-BAF mutant (BAF-A12T) and a BAF 
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Figure 1: NGPS BAF mutation affects nuclear morphology, induces lamin A/C and prelamin A distribution defects. 
(A) BAF (green) and lamin A/C (red) localization in control and Nestor-Guillermo Progeria Syndrome (NGPS) cells. Asterisk: nuclear 
enlargement, arrow: nuclear bleb. Nuclei are costained by DAPI. Bar 10 μm. (B) The percentage of cells showing nuclear alterations is 
reported in the graph as means ± S.D. of three different counts (100 nuclei per count). Asterisk: statistically significant difference at the 
Student’s t-test (P < 0.05). (C) Higher magnification of NGPS nucleus indicated by arrow in A. Arrowhead: honeycomb. (D) Prelamin 
A (red) and BAF (green) immunofluorescence detection in control (cont.) and NGPS mevinolin treated cells. Arrows: prelamin A/BAF 
colocalization at the nuclear periphery. Arrowheads: nuclei with intranuclear prelamin A aggregates. DNA was stained by DAPI. Bar 10 µm. 
(E) Higher magnification of control (cont.) and NGPS nuclei with prelamin A intranuclear aggregates indicated by arrowheads in D. In a 
control nucleus prelamin A/BAF costained intranuclear aggregates are indicated by arrows while in NGPS nucleus prelamin A intranuclear 
aggregates missing BAF staining are indicated by arrowheads. Percentage of prelamin A/BAF overlapped aggregates is indicated. The 
percentages of prelamin A foci colocalized with BAF foci are indicated. At least 100 cells were analyzed for each experiment. Data are 
presented as mean ± S.D. (*P < 0.001). (F) Higher magnification of NGPS cell nucleus indicated by arrow in D. Arrow: honeycomb 
structures. 
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mutant unable to interact with nuclear envelope proteins 
(BAF-G47E) [17], [18], [8], [22]. Since, we previously 
demonstrated, in accordance with other authors [23] and 
[24], that the overexpression of LA-WT causes not only 
lamin A increase but also a definite level of prelamin A 
accumulation [17, 18], we harvested transfected cells 
24 hour post-transfection. In this way, prelamin A protein 
amount in LA-WT expressing cells is lower than lamin A 
[17], [18].
The localization and expression of GFP-tagged 
proteins were evaluated (Figure 3A and Figure S2A). BAF-
WT and BAF-A12T showed a similar cytoplasmic/nuclear 
distribution while BAF-G47E localized exclusively in the 
nucleoplasm (Figure 3A arrow). The expression of BAF-
WT in combination with LA-WT or LA-C661M induced 
BAF-WT nuclear recruitment (Figure 3B–3C arrowheads) 
[17]. On the contrary, BAF-A12T mutant localization was 
slightly affected by expression of FLAG-tagged lamins. 
In particular, cytoplasmic GFP-BAF-A12T staining was 
still detectable (Figure 3B–3C arrows and Figure S4) and 
the nuclear rim signal increase was very low. As expected, 
BAF-G47E did not change at all its nucleoplasmic 
distribution (Figure 3B–3C and Figure S4). The analysis 
of the fluorescence intensity profile confirmed BAF-A12T 
and BAF-G47E translocation defects (Figure S4). Western 
blotting analysis showed that exogenous proteins were 
expressed at similar levels and at the predicted molecular 
weight (Figure S2A). 
Anti-FLAG immunoprecipitation experiments 
performed in cotransfected cells showed a minor BAF-
A12T interaction with both LA-WT and LA-C661M 
compared with BAF-WT recovery. As expected, a faint 
band corresponding to BAF-G47E was observed only after 
a long exposure time (Figure 3D). 
Figure 2: NGPS BAF mutation impairs prelamin A-related H3K9m3 intranuclear clustering. (A) Prelamin A (red) and 
histone H3 trimethylated at lysine 9 (H3K9m3, green) localization in control fibroblasts untreated or treated with mevinolin. DNA staining 
with DAPI is shown in merge (merge + DAPI). Bar 10 µM. (B) Prelamin A (red) and H3K9m3 (green) localization in NGPS fibroblasts 
untreated or treated with mevinolin. DNA staining with DAPI is shown in merge (merge + DAPI). Bar 10 µM. (C) Higher magnification 
of nuclei showed in A and B (squares). Prelamin A (red), histone H3K9m3 (green) and merge without DAPI staining are shown. Arrow: 
prelamin A-H3K9m3 costained intranuclear aggregate; arrowhead: prelamin A intranuclear aggregate in which H3K9m3 staining is 
missing. The percentage of prelamin A-H3K9m3 colocalized spots is reported. (D) Statistical analysis. The graph shows the percentage of 
nuclei showing clustered H3K9m3 in control and NGPS cells. White bars: control cells untreated (–) or mevinolin treated (+); black bars: 
NGPS cells untreated (–) or mevinolin treated (+). Values are means of two independent experiments ± S.D.; for each experiment a total of 
100 nuclei were considered. (*P < 0.004), (**P < 0.001). (E) The percentages of prelamin A foci colocalized with H3K9m3 are indicated. 
Values are means of two independent experiments ± standard deviation. At least 100 cells were analyzed for each experiment. (*P < 0.001).
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Prelamin A induces HP1-alpha and LAP2-alpha 
nuclear relocalization by interacting with BAF
Since the BAF mutation occurring in NGPS cells 
not only compromises prelamin A-BAF interaction but 
also impairs prelamin A-mediated H3K9m3 intranuclear 
recruitment, we wondered if this last alteration could also 
be caused by anomalous interaction of prelamin A and 
BAF. To this aim we evaluated the effect of prelamin A on 
chromatin marker distribution in models where prelamin 
A and BAF fail to interact properly. 
The expression of prelamin A is reported to induce 
HP1-alpha clustering without any effects on protein 
level [25, 26]. A similar result was obtained in HEK293 
expressing prelamin A constructs (Figure S3). On the 
contrary, HP1-alpha localization was unaffected by the 
expression of GFP-empty vector or GFP-BAF constructs 
(Figure S2B and 4A).
In cells expressing prelamin A constructs (LA-WT 
and LA-C661M) in combination with BAF-WT, HP1-
alpha nuclear periphery recruitment was detectable 
(Figure 4A’–4A” and 4a’–4a” arrowheads) while in cells 
expressing prelamin A constructs in combination with 
BAF mutants, the effect on HP1-alpha was impaired 
(Figure 4A’–4A” arrows and 4a’–4a”). However, in LA-
C661M/BAF-A12T expressing cells, a barely detectable 
HP1-alpha staining was perceptible at the nuclear rim 
(Figure 4A”and a” asterisks). Western blotting analysis 
showed that this result was not related to protein amount 
or molecular weight changes (Figure S2B).
To strengthen our finding, we evaluated also LAP2-
alpha [25]. This nucleoplasmic protein interacts with 
intranuclear lamins, and the accumulation of prelamin A 
modifies its localization [25]. In cells expressing prelamin 
A constructs alone or in combination with BAF-WT, we 
observed that LAP2-alpha was located at the nuclear 
Figure 3: Evaluation of BAF mutants localization and interaction with prelamin A. (A) GFP-BAF mutants localization in 
HEK293 cells. GFP-empty vector (mock), BAF-WT, BAF-A12T and BAF-G47E localization in combination with DAPI staining is shown. 
Bar 10 µM. (B) GFP-BAF-mutants localization in FLAG-tagged wild type lamin A (LA-WT) expressing cells. (C) GFP-BAF-mutants 
localization in FLAG-tagged prelamin A (LA-C661M) expressing cells. In B and C FLAG staining (red), GFP signal (green). Arrowheads: 
nuclear lamina GFP localization; arrows: cytoplasmic GFP distribution. DAPI staining is shown in merge. Bar 10 µM. Images shown 
are representative of 80% of transfected cells. (D) Coimmunoprecipitation study performed in HEK293 cells transfected with LA-WT or 
LA-C661M in combination with GFP-BAF constructs. Western blotting analysis of FLAG and GFP-tagged proteins in whole lysate and 
coimmunoprecipitated complexes (FLAG-IP) are shown. No proteins staining was observed in absence of anti-FLAG antibody (A/G). Two 
different exposures, short (a) and long (b), are shown.
Oncotarget15667www.impactjournals.com/oncotarget
Figure 4: BAF governs HP1-alpha and LAP2-alpha nuclear relocalization in prelamin A accumulating cells. (A) HP1-
alpha (HP1α) localization in HEK293 cells expressing FLAG-tagged lamin constructs in combination with GFP-BAF mutants. Top line: 
HP1α nuclear distribution in untransfected cells. HP1α staining (grey) is combined with DAPI (HP1α+DAPI). Bar 10 µM. A’) HP1α 
localization in cells expressing wild type lamin A (LA-WT+) in combination with BAF-WT or BAF-A12T or BAF-G47E. FLAG staining 
(red), GFP (green), HP1α (grey). Bar 10 µM. a’) Density dot plot of FLAG and HP1α colocalization staining showed in A'. FLAG (red), 
HP1α (white), merge (blue). Arrowhead: FLAG/HP1α colocalization. A”) HP1α localization in HEK293 cells expressing prelamin A 
(LA-C661M+) in combination with BAF-WT, BAF-A12T, BAF-G47E. FLAG staining (red), GFP (green), HP1α (grey). Bar 10 µM. a”) 
Density dot plot of FLAG and HP1α colocalization staining showed in A". FLAG (red), HP1α (white), merge (blue). Arrowhead and asterisk 
indicate FLAG/HP1α colocalization. In panel (A') and (A") arrowheads indicate HP1α nuclear periphery localization increase relative to 
untransfected cells (shown in top line); arrows: HP1α intranuclear localization pattern; asterisk: partial HP1α nuclear lamina localization 
pattern. Images shown are representative of 80% transfected cells. (B) LAP2-alpha (LAP2α) localization in HEK293 cells expressing 
FLAG-tagged lamin constructs in combination with GFP-BAF mutants. In the top line LAP2α nuclear distribution in untransfected cells. 
LAP2α staining (grey) is combined with DAPI (LAP2α+DAPI). Bar 10 µM. B’) LAP2α localization in cells expressing wild type lamin A 
(LA-WT+) in combination with BAF-WT or BAF-A12T or BAF-G47E. FLAG staining (red), GFP (green), LAP2α (grey). Bar 10 µM. b’) 
Density dot plot of FLAG and LAP2α colocalization staining shown in B'. FLAG (red), LAP2α (grey), merge (blue). Arrowhead: FLAG/
LAP2α colocalization. Arrow: absence of LAP2α staining at the nuclear periphery. (B”) LAP2α localization in HEK293 cells expressing 
FLAG-tagged wild type prelamin A (LA-C661M+) BAF-WT or BAF-A12T or BAF-G47E. FLAG staining (red), GFP (green), LAP2α 
(grey). Bar 10 µM. b”) Density dot plot of FLAG and LAP2α colocalization shown in B". FLAG (red), LAP2α (white), merge (blue). 
Arrowhead; FLAG/LAP2α colocalization. Asterisk: partial FLAG/LAP2α colocalization. Arrow: absence of LAP2α staining at the nuclear 
periphery. In (B') and (B") arrowheads indicate LAP2α nuclear periphery localization, arrows indicate LAP2α nucleoplasmic distribution, 
empty arrowheads indicate a partial LAP2α nuclear lamina recruitment, asterisk indicate a more detectable LAP2α nuclear lamina staining 
observed in LA-C661M+BAF-A12T expressing cells. Images are representative of 80% transfected cells. (C) LA-WT and LA-C661M 
coimmunoprecipitation experiment performed in cotransfected cells. Protein complexes recovered by anti-FLAG antibody (FLAG-IP) 
as well as whole lysates were subjected to FLAG, GFP, HP1α and LAP2α Western blotting detection. No protein bands were observed in 
protein A/G negative control (A/G).
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periphery (Figure S3 asterisk and Figure 4B’–4B” and 
4b’–4b” arrowheads). On the contrary, in untransfected 
cells or in cells expressing singularly any BAF construct, 
LAP2-alpha nucleoplasmic localization did not change 
(Figure 4B and Figure S2C). Interestingly, a decrease in 
prelamin A ability to modify the nuclear distribution of 
LAP2-alpha was observed when prelamin A constructs 
were expressed in combination with BAF mutants (Figure 
4B’–4b’ and 4B”–4b”). The nuclear lamina recruitment of 
LAP2-alpha was abolished by BAF-G47E co-expression 
(Figure 4B’–4b’ and 4B”–4b”’ arrows), but it still partially 
occurred when cotransfected with BAF-A12T (Figure 4B 
empty arrowheads). In particular, we observed that the 
BAF-A12T inhibitory effect on LAP2-alpha nuclear 
periphery repositioning was more evident when LA-WT 
was coexpressed (Figure 4B’–4b’). Differently, LA-
C661M coexpression left a faint LAP2-alpha nuclear 
rim staining (Figure 4B”–4b” asterisks). Western 
blotting analysis showed that the LAP2-alpha protein 
level was not affected by exogenous protein expression 
(Figure S2C). In addition, the evaluation of fluorescence 
intensity profiles confirmed these results (Figure S4). A 
coimmunoprecipitation study performed in cotransfected 
cells demonstrated that BAF mutants were able to decrease 
prelamin A interaction with LAP2-alpha and HP1-alpha 
(Figure 4C). These results are in accordance with the 
known preferential BAF interaction with prelamin A [17], 
[18]; indeed, prelamin A (LA-C661M) partially affects 
chromatin organization (HP1-alpha and LAP2-alpha 
recruitment at the nuclear periphery) also when BAF-
prelamin A binding is compromised (prelamin A/BAF-
A12T complex). On the contrary, in lamin A (LA-WT) 
expressing cells the prelamin A protein amount seems 
to be insufficient, although increased, to overcome the 
impairment of prelamin A/AF-A12T interaction.
We confirmed our results in BAF-siRNA treated 
HEK293 cells expressing prelamin A constructs (Figure 5). 
BAF reduction (Figure 5A–5B) elicited LA-WT and LA-
C661M localization defects (Figure 5C arrowheads). As 
already observed in NGPS cells, transfected nuclei were 
characterized by FLAG staining rarefaction at the nuclear 
lamina. In accordance, the prelamin A mediated effects 
on HP1-alpha and LAP2-alpha nuclear localization are 
undetectable (in the case of HP1-alpha) (Figure 5C empty 
arrows) or partially detectable (in the case of LAP2-alpha) 
(Figure 5C). In particular, some nuclear periphery LAP2-
alpha aggregates were observed in LA-C661M expressing 
cells (Figure 5C arrow), however a complete nuclear 
lamina recruitment of LAP2-alpha without nucleoplasmic 
staining was never observed. HP1-alpha, LAP2-alpha 
and FLAG tagged protein amounts were unaffected by 
siBANF1 silencing (Figure 5A).
Prelamin A-BAF interaction affects chromatin 
organization
To evaluate the influence of BAF on chromatin 
organization due to prelamin A, we performed an electron 
microscopy study on HEK293 cells expressing FLAG-
tagged proteins in combination with BAF constructs. 
Untransfected cells showed a heterochromatin layer at 
the nuclear periphery, underlying the normally organized 
nuclear envelope (Figure 6 Unt.-u-u’ arrows). Cells 
expressing LA-WT in combination with BAF-WT 
showed a normal chromatin organization with increase of 
heterochromatin clusters located at the nuclear periphery 
(Figure 6A–6a–6a’ arrows). 
On the contrary, when LA-WT was expressed 
in combination with BAF-A12T, the peripheral 
heterochromatin did not adhere to the nuclear lamina. In 
addition, the architecture of the nuclear wall was affected, 
as an aberrant duplication of the nuclear lamina and 
nuclear envelope was often detectable (Figure 6B–6b–6b’ 
star/arrows).
The coexpression of LA-WT with BAF-G47E had 
no effect on chromatin organization. The ultrastructural 
appearance of HEK293 nuclei expressing this construct 
combination was similar to that observed in untransfected 
cells, even thought a mild-grade heterochromatin loss with 
nuclear lamina detachment was observed (Figure 6C–6c–6c’ 
arrows). 
The combination of LA-C661M with BAF-WT 
induced the recruitment of heterochromatin clumps at 
the nuclear lamina with an impressive beads-on-a-string 
appearance (Figure 6D–6d–6d’ arrows). Interestingly, the 
combination of LA-C661M with BAF-A12T or BAF-
G47E impeded the beads-on-a-string chromatin clustering 
while some heterochromatin clustering was observed 
(Figure 6E–6e–6e’arrows and 6F–6f–6f’ arrows).
BAF mediates LAP2-alpha nuclear relocalization 
caused by progerin
Considering that progerin, a mutated form of 
prelamin A accumulated in HGPS cells, interacts with BAF, 
we wondered if the progerin-BAF complex could affect 
LAP2-alpha nuclear distribution in these cells. To this aim, 
we first evaluated LAP2-alpha localization and expression 
in cells from patients affected by Hutchinson-Gilford 
Progeria Syndrome (Figure 7A). Using methanol fixation, 
we could unveil a peculiar LAP2-alpha distribution linked 
to progerin accumulation [27]. In control cycling cells, 
LAP2-alpha nucleoplasmic localization was observed 
(Figure 7A asterisk). In contrast, progerin increase in 
HGPS cells reduced intranuclear LAP2-alpha staining and 
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induced a clustered nuclear lamina localization (Figure 7A 
arrowhead and Figure 7A’) bearing perfect colocalization 
with progerin. LAP2-alpha nuclear redistribution was not 
related with its amount (Figure 7B).
For evaluating BAF involvement in progerin-
mediated effects on LAP2-alpha localization, we expressed 
FLAG-tagged progerin (FLAG-∆50) in HEK293 cells 
(Figure S3). Endogenous BAF recruitment at the nuclear 
rim of FLAG-∆50 expressing cells was observed, but 
aggregates were formed (Figure S3 asterisk). When GFP-
tagged BAF-WT was expressed in combination with FLAG-
∆50 a similar distribution was observed (Figure 7C arrow), 
interestingly FLAG-∆50 was not able to recruit the BAF-
G47E mutant at the nuclear lamina (Figure 7C arrowhead). 
Coimmunoprecipitation studies revealed that 
FLAG-∆50 was able to bind BAF-WT but failed to bind 
BAF-G47E mutant (Figure 7D). More interestingly, 
BAF-G47E was able to abrogate FLAG-∆50 influence on 
LAP2-alpha nuclear localization without causing effects at 
the protein level (Figure 7E–7F–7G). 
DISCUSSION
Chromatin disorganization is one of the main 
characteristics of laminopathies with prelamin A processing 
defects. Accumulation of different prelamin A forms highly 
modifies the structural and genetic organization of the 
nucleus [11], and pharmacological approaches reducing 
Figure 5: BAF depletion interferes with prelamin A-mediated HP1-alpha and LAP2-alpha nuclear relocalization. 
(A) Western blotting evaluation of total lysates from HEK293 cells subjected to BAF depletion by siRNA treatment. Cells treated 
with scramble or BANF1 siRNA (siBANF1) were untransfected (–) or transfected with LA-WT or LA-C661M constructs. FLAG, 
LAP2α, HP1α and BAF proteins bands are shown. Actin: protein loading control. Western blotting densitometric analysis is reported. 
(B) Immunofluorescence evaluation of BAF in HEK293 cells treated with scramble or BANF1 siRNA. BAF (green) and DNA staining 
(DAPI) are shown. Bar 10 mm. (C) Immunofluorescence detection of LA-WT, LA-C661M, HP1α and LAP2α in cells treated with scramble 
siRNA or siBANF1. FLAG (red), HP1α and LAPα (green). DNA was costained by DAPI and shown in merge. Arrowheads: nuclear lamina 
rarefaction staining of FLAG tagged proteins. Empty arrows: absence of the HP1α nuclear periphery staining increase. Arrow indicates 
the defective LAP2α nuclear periphery recruitment. Higher magnification of nuclear periphery distribution of HP1α and LAP2α staining, 
merged with DAPI, is shown. Bar 10 μm.
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the prelamin A protein level can at least in part limit 
deleterious effects on nuclear functions [28–30]. 
Thus, the identification of prelamin A-binding 
proteins able to influence chromatin organization by 
connecting prelamin A with chromatin, is a major goal, 
in order to develop to intervening therapies to contrast the 
damage induced by prelamin A.
In this regard, we previously identified BAF as 
a possible prelamin A molecular mediator involved 
in chromatin organization defects which characterize 
prelamin A linked diseases [18]. In our previous study we 
demonstrated in vivo prelamin A-BAF interaction and, 
more interestingly, we observed that BAF was retained in 
the nucleus in all prelamin A-accumulating diseases [17], 
[18] suggesting a functional link between prelamin A and 
BAF. Since a human BAF proteome analysis revealed 
56 high-confidence targets in a single cell type, including 
multiple proteins that regulate histone modifications 
[9] and because BAF both stabilizes the nuclear lamina 
structure and influences chromatin organization [19], 
we wondered if BAF could be a possible prelamin 
A modulator. The study we report here on prelamin 
Figure 6: Electron microscopy evaluation of prelamin A/BAF complex effects on chromatin organization. Electron 
microscopy evaluation of HEK293 nuclei in untransfected (Unt.) or prelamin A and BAF constructs cotransfected cells. (Unt.) Ultrastructural 
organization of untransfected HEK293 cell nucleus. (u) Enlargement of nuclear periphery. (u’) Density dot plot of picture showed in (u). Red 
arrowheads: peripheral heterochromatin. (A) Nucleus of cell expressing LA-WT in combination with BAF wild BAF-WT. (a) Enlargement 
of nuclear periphery. (a’) Density dot plot of picture showed in (a). Red arrowheads: heterochromatin. (B) Nucleus of cell expressing LA-
WT in combination with BAF-A12T. (b) Enlargement of nuclear periphery. (b’) Density dot plot of picture showed in (b). Red arrowheads: 
peripheral heterochromatin detachment. Red star: detached heterochromatin clump. (C) Nucleus of cell expressing LA-WT in combination 
with BAF-G47E. (c) Enlargement of nuclear periphery. (c’) Density dot plot of picture showed in (c). Red arrowheads: heterochromatin 
rarefaction. (D) Nucleus of cell expressing LA-C661M in combination with BAF-WT. (d) Enlargement of nuclear periphery. (d’) Density 
dot plot of picture showed in (d). Red arrowheads: “beads-on-a-string appearance” heterochromatin. (E) Nucleus of cell expressing LA-
C661M in combination with BAF-A12T. (e) Enlargement of nuclear periphery. (e’) Density dot plot of picture showed in (e). Arrowheads: 
heterochromatin. (F) Nucleus of cell expressing LA-C661M in combination with BAF-G47E. (f) Enlargement of nuclear periphery. 
(f’) Density dot plot of picture showed in (f). Red arrowheads: heterochromatin. Representative images of chromatin organization observed 
in 70% of analyzed nuclei, for each cotransfection experiment, are shown.
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Figure 7: BAF is involved in the LAP2-alpha nuclear distribution observed in progerin expressing cells. (A) Localization 
of LAP2α and progerin in control and HGPS cells. LAP2α (green), progerin (red). DNA staining with DAPI is showed in merge. Bar 
10 μm. Asterisk: LAP2α nucleoplasmic distribution. Arrowhead: HGPS nucleus shown at higher magnification in A'. (B) Western 
blotting evaluation of LAP2α and lamin A/C in control and HGPS cells. Actin: protein loading control. Densitometric analysis of LAP2α 
immunoblotted bands was performed in triplicate experiments. (C) BAF-WT and BAF-G47E localization in cells expressing LA-WT or 
progerin construct (FLAG-LA-∆50). FLAG (red), GFP (green). DNA staining with DAPI is shown in merge. Bar 10 μm. Arrow: BAF-
WT nuclear periphery aggregates. Arrowhead: BAF-G47E nucleoplasmic localization. Images are representative of 80% of transfected 
cells. (D) Western blotting evaluation of coimmunoprecipitation performed in cotransfected cells. FLAG, GFP and LAP2α immunoblotted 
bands obtained from whole lysates and anti-FLAG immunoprecipitation (FLAG-IP) samples are shown. No protein bands were detected 
in protein A/G (A/G) negative control. Densitometric analysis of FLAG, GFP and LAP2α immunoblotted bands is shown. Values are 
means of three independent experiments ± S.D. (*P < 0.001). (E) LAP2α nuclear distribution in cells coexpressing LA-∆50 and BAF-WT 
or progerin unbinding mutants BAF-G47E. FLAG (red), GFP (green), LAP2α (grey). DNA staining performed with DAPI is excluded in 
merge. Images shown are representative of 75% of cotransfected cells. (F) Fluorescence intensity profile along arrows drawn in (E). The top 
graph indicates intensity profile of BAF-WT (green), LA-∆50 (red), LAP2α (white) and DAPI (blue). The bottom graph indicates intensity 
profile of BAF-G47E (green), LA-∆50 (red), LAP2α (white) and DAPI (blue). (G) Western Blotting evaluation of LAP2α in HEK293 cells 
untransfected or transfected with LA-WT or LA-∆50 in combination with wild type BAF (WT) or (G47E). Immunoblotted bands obtained 
from detection of whole lysates are shown. LAP2α, FLAG, GFP. Actin: protein loading control. 
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A accumulation effects on chromatin organization in 
NGPS cells lends evidence to this hypothesis (Figure 7). 
In particular we observe that A12T-mutated BAF not 
only affects nuclear morphology, but leads to lamin A/C 
localization defects and, more interestingly, interferes with 
the typical H3K9m3 intranuclear clustering induced by 
non-farnesylated prelamin A accumulation. In NGPS cells 
lamin A biogenesis is normal and mevinolin administration 
results in prelamin A increases both at the nuclear lamina 
and at intranuclear aggregates, as expected. Nevertheless, 
the expression of prelamin A and its colocalization with 
BAF-A12T and H3K9m3 at intranuclear aggregates 
appear anomalous, suggesting that the integrity of the 
BAF-prelamin A protein platform could be affected by 
the BAF-A12T mutation, which, in turn, also leads to 
functional impairment of prelamin A mediated chromatin 
organization. In accordance, we observe that though the 
BAF-A12T mutation does not affect BAF dimerization or 
BAF binding to either DNA or emerin [21], its ability to 
interact with lamin A and prelamin A is reduced. Thus, in 
NGPS cells the decrease in prelamin A capacity to recruit 
BAF in the nucleus combined with a reduction in the 
amount of BAF protein [21] could damage the function of 
the protein platform governed by prelamin A.
It has been previously described that BAF is 
necessary for proper lamin A/C localization [31], that 
lamin A and prelamin A bind BAF directly [32], [10] and 
that lamin A and BAF influence each other’s localization 
[33], [31]. In the absence of lamin A/C, BAF localizes 
exclusively in the cytoplasm and seems to be unable 
to translocate into the nucleus. BAF has a reciprocal 
influence on lamin A/C localization. Consistent with this 
notion, we observed lamin A/C honey-comb structures 
in NGPS cells. Therefore, it is conceivable that the 
decrease in both lamin A/BAF capability to interact 
reciprocally and in the BAF protein level observed in 
NGPS cells, mimic BAF depletion causing a secondary 
lamin A misfunction. On the other hand, secondary lamin 
A defects could further worsen BAF defects in NGPS 
trough a feedback loop. In addition, the NGPS-BAF 
mutation impedes the proper localization of emerin. In 
NGPS cells emerin loses its nuclear distribution and is 
found predominantly in the cytoplasm [21]. Interestingly, 
emerin interacts with prelamin A in vivo [34] suggesting 
that the NGPS-BAF mutation could perturb the prelamin 
A-BAF platform by affecting the binding partners needed 
for proper localization of prelamin A. Indeed emerin is 
necessary for the intranuclear localization of prelamin A 
Figure 8: Speculative cartoon of the mechanism involving prelamin A-BAF interaction in chromatin organization 
change. In normal cells BAF localizes both at the cytoplasm and in the nucleus. At the nuclear level BAF is distributed close to the 
inner nuclear membrane where it interacts with LEM-proteins (LAP2, emerin and MAN1) as well as in the nucleoplasm where it binds 
intranuclear form of LAP2: LAP2α. Lamin B receptor (LBR) and heterochromatin binding protein 1 alpha (HP1α) are involved in the 
organization of heterochromatin. The accumulation of prelamin A/progerin affects BAF localization in the cell influencing chromatin 
organization. In particular, the accumulation of lamin A precursors induce BAF translocation from the cytoplasm to the nuclear lamina 
where prelamin A and BAF interact. BAF mediates prelamin A accumulation effects on chromatin organization. Prelamin A takes advantage 
of BAF interaction with DNA and DNA organizing proteins to modify chromatin organization as demonstrated by LAP2α and HP1α 
nuclear relocalization.
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aggregates, as demonstrated by prelamin A mislocalization 
observed in emerin null cells treated to accumulate lamin 
A precursor [34]. 
The pathogenic BAF mutation leads to nuclear 
misshaping, increased size, lobulation and blebbing [21]. 
In analogy with genetic disorders due to mutations in 
the nuclear lamina and nuclear envelope components, 
we observe that such irregular nuclei are characterized 
by abnormalities in chromatin organization related to 
epigenetic changes such as trimethylation of histone H3 at 
Lys9 and Lys27, histone H4 at Lys20 and the acetylation 
of histone H4 at Lys16 [35–37]. NGPS skin fibroblasts 
are characterized by loss of H3K9me3 which becomes 
more evident when prelamin A is accumulated. The 
decrease of H3K9me3 staining observed in NGPS cells is 
in accordance with the proposed BAF epigenetic function 
[9]. BAF interacts with nucleosomes and directly binds 
histone H3 and H4 influencing nucleosome accessibility 
to chromatin or, alternatively, recruiting specific regulators 
to chromatin [19]. In particular BAF interacts with the 
dimethyltransferase G9a [19]. This enzyme is responsible 
for H3-K9 dimethylation, a secondary histone modification 
necessary to silence chromatin via Suv39 h1 action. 
Interestingly BAF overexpression, as well as prelamin A 
accumulation, increases trimethylation status of histone 
H3 on lysine 9 [19]. In NGPS cells, such an epigenetic 
marker is strongly reduced and prelamin A accumulation 
fails to affect H3K9me3 intranuclear localization. These 
findings suggest that the BAF-A12T mutation could 
perturb the epigenetic function of BAF affecting its ability 
to interact with histone H3 or with enzymes involved in 
histone H3 secondary modification. 
We confirmed our results in NGPS cells using an 
experimental model. Specific markers related to chromatin 
organization and dynamics, HP1-alpha and LAP2-alpha 
[25], were evaluated under conditions of impaired 
prelamin A-BAF interaction. We expressed prelamin A in 
combination with BAF-G47E, a BAF mutant whose ability 
to interact with histone H1/H3, inner nuclear membrane 
proteins (emerin and MAN1) [8] and prelamin A 
(this paper) is severely reduced. We observed that the 
expression of prelamin A constructs in combination with 
BAF-WT induced localization of BAF at the nuclear 
lamina, reorganization of HP1-alpha distribution and 
LAP2-alpha recruitment to the nuclear periphery, while 
in combination with BAF-A12T or BAF-G47E, decreased 
or abolished, respectively, BAF localization to the nuclear 
lamina as well as both HP1-alpha and LAP2-alpha 
relocalization in the nucleus were decreased or abolished 
respectively. Notably, in HGPS cells, recruitment of 
LAP2alpha to the nuclear periphery is mediated by 
WT-BAF and does not occur in the presence of BAF 
mutants. These findings allowed us to speculate about 
the possible molecular mechanism involved in progeroid 
syndromes linked to prelamin A processing defects and 
BAF mutations. 
Aging is a complex process in which the most 
prominent hallmark is the accumulation of various types 
of DNA damage; among these, DSBs (DNA Double-
Strand Breaks) are the most deleterious [38, 39]. In 
addition, aging brings about dramatic changes in the 
packaging of DNA into higher-order chromatin structures 
[40]. Perhaps the most significant of these changes are 
both the global loss of highly condensed, transcriptionally 
silent heterochromatin [41] and the alteration in histone 
composition during replicative aging [42–44]. In progeroid 
syndromes, due to prelamin A processing impairment, 
heterochromatin loss and a deficiency in DNA-repair 
processes have been described [45], [46]. 
Interestingly BAF binding with proteins involved in 
the DNA damage response has been reported [9]. In NGPS 
cells, BAF mutation could interfere directly with such 
functions while in HGPS cells the persistence of BAF-
progerin binding could impair BAF interactions or slow 
down the dynamics of BAF protein complexes. In this 
regard, it has been recently demonstrated that prelamin 
A accumulation affects the mobility of the BAF binding 
protein HP1-alpha following DNA damage, strengthening 
its nuclear matrix association [47]. The delay in γ-H2AX 
foci formation demonstrates that the persistence of an 
heterochromatin status impedes DNA damage repair [47]. 
We observed that BAF is necessary to mediate both 
prelamin A and progerin effects on LAP2-alpha nuclear 
distribution. LAP2-alpha interacts with High Mobility 
Group nucleosome-binding proteins (HMGN) 5 [48]. The 
HMG class of proteins affects chromatin-related processes 
such as transcription, replication, and repair [49] causing 
changes in chromatin structure or at the level of histone 
post-translational modifications. LAP2-alpha is able to 
influence the nuclear distribution and mobility of HMGN5 
[48], suggesting that this LEM-protein could indirectly 
affect the overall chromatin organization and influence the 
activation of specific DNA sequences. 
Thus, prelamin A and progerin accumulation could 
also modify HMGN5 distribution across the genome 
through the control of LAP2-alpha nuclear localization, 
influencing gene expression in a pro-aging way [48].
However, further studies need to be performed in 
order to unveil the nuclear pathway specifically affected by 
the impairment of BAF function and, more interestingly, 
identify those common molecular events that enhance 
aging progression in NGPS and progeroid laminopathies.
MATERIALS AND METHODS
Cell cultures, transfection and siRNA
Skin fibroblast cultures were obtained from skin 
biopsies of healthy, NGPS [21] HGPS (culture passage 
numbers 10–15) [41] and RD (culture passage numbers 
12–16) [50] patients following a written consent. Cultured 
were established and cultured in Dulbecco’s modified 
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Eagle’s medium supplemented with 10% fetal calf serum 
(FCS) and antibiotics. For transfection experiments 
HEK293 cells were used. GFP-BAF and the mutated 
constructs BAF-A12T, BAF-G47E, full length FLAG-
tagged prelamin A (LA-WT, pCI mammalian expression 
vector) and the mutated construct LA-C661M were 
transiently transfected into HEK293 cells using FuGene6 
reagent (Roche). The transfection efficiency was over 
75%. Biochemical and immunofluorescence analysis 
were performed 24 h after transfection. BAF depletion by 
siRNA treatment (Santa Cruz biotechnology SC-44804) 
was performed according to the manufacturer’s protocol. 
In human skin fibroblast cells, the accumulation of 
prelamin A was obtained using 25 µM mevinolin (Sigma) 
in growth medium for 18 h. 
Western blotting and immunoprecipitation
For Western blotting evaluation HEK293 
untransfected or transfected cells were processed in lysis 
buffer containing 20 mM Tris-HCl, pH 7.5, 1% SDS, 
1 mM Na3VO4, 1 mM PMSF, 5% β-mercaptoethanol 
and protease inhibitors. Protein were subjected to SDS 
gradient gel (5–20%) electrophoresis and transferred to 
nitrocellulose membrane overnight at 4°C. Incubation with 
primary antibodies was performed for the indicated time. 
Bands were revealed by the Amersham ECL detection 
system. For coimmunoprecipitation experiments in order 
to evaluate tagged proteins interaction (FLAG-lamin A 
constructs and GFP-BAF constructs), HEK293 transfected 
cells were lysed in a buffer containing 50 mM TRIS-
HCl, pH 8.0, 150 mM NaCl, 1% NP40, 0.1% SDS and 
protease inhibitors (IP-buffer). Lysates were incubated 
with specific antibodies overnight at 4°C. Control 
immunoprecipitation were performed in the presence of 
aspecific immunoglobulins. After the addition of 30 µl 
of protein A/G (Santa Cruz Biotechnology) for 45 min at 
4°C, immunoprecipitated protein complexes were washed, 
added to Laemmli’s buffer, boiled and subjected to western 
blot analysis. To evaluate Lap2-alpha and Hp1-alpha 
interaction with lamin A/BAF protein platform a 
previously described methods was used [25]. Briefly, HEK 
293 transfected cells were fixed in 1% formaldehyde in 
PBS1X for 10 min at room temperature, and then lysed 
in buffer containing 1% SDS, 10 mM EDTA, 50 mM 
Tris-HCl pH 8.0 plus protease inhibitors. Cells were 
lysed by glass beads (Sigma) and thereafter by sonication. 
Immunoprecipitation was performed overnight at 4°C. 
Immunoprecipitated protein complexes were washed and 
subjected to Western blot analysis. 
Immunofluorescence
Human fibroblast and HEK293 transfected cells 
grown on coverslips were fixed in 4% paraformaldehyde 
at 4°C for 10 min and permeabilized with 0.15% Triton 
X-100 for 5 min and in methanol at –20°C for 7 minutes. 
Samples were incubated with PBS containing 4% BSA to 
saturate non-specific binding and incubated with primary 
antibodies and secondary antibodies. The nuclei were then 
counterstained with 4, 6-diamino-2-phenylindole (DAPI). 
The slides were mounted with an anti-fade reagent in 
glycerol and observed. Immunofluorescence microscopy 
was performed using a Nikon E600 epifluorescence 
microscope and a Nikon oil-immersion objective [100x 
magnification, 1, 3 NA (numerical aperture)]. Photographs 
were taken using a Nikon digital camera (DXm) and NIS-
Element AR software. Confocal imaging was performed 
using a laser-scanning motorized confocal system (Nikon 
A1R, Nikon, Amsterdam, Netherlands) equipped with 
an Eclipse Ti-E inverted microscope and four laser lines 
(405, 488, 561, and 638 nm). Images were acquired with 
a Nikon 100x PlanApo Oil 1.4 NA oil objective. For each 
type of quantification, laser intensities and camera settings 
were maintained identically within the same experiment to 
allow comparison of different cell expressing constructs. 
Localization, colocalization and mean intensity analysis 
were performed using NIS-Element AR. Images were 
processed using Adobe Photoshop (Adobe Systems).
Electron microscopy
Pellets from HEK293 transfected cells were fixed 
with 2.5% glutaraldehyde 0.1 M cacodylate buffer, pH 7.3. 
After post-fixation with 1% osmium tetroxide (OsO4) 
in cacodylate buffer for 1 h, pellets were dehydrated in 
an ethanol series, infiltrated with propylene oxide and 
embedded in Epon resin. Ultrathin sections were stained 
with uranyl acetate and lead citrate (15 min each) and 
were observed with a Jeol Jem-1011 transmission electron 
microscope, operated at 100 kV. At least 100 nuclei per 
sample were observed.
Antibodies
The antibodies employed for western blot analysis 
or immunofluorescence labeling were: anti-FLAG, 
mouse monoclonal (Sigma M2, diluted 1:300, 1 h, for 
the immunofluorescence analysis and 1:1000, 1 h, for 
the Western blot analysis); anti-BAF, rabbit polyclonal 
(Santa Cruz Biotechnology FL-89, diluted 1:10, overnight 
at 4°C for immunofluorescence analysis; anti-GFP rabbit 
polyclonal (Santa Cruz Biotechnology FL, diluted 1:1000 
for 1 h, for the Western blot analysis); anti-prelamin A, 
goat polyclonal (Santa Cruz Biotechnology SC-6214, 
used 1:100 overnight at 4°C for the immunofluorescence 
analysis) anti-lamin A/C, goat polyclonal (Santa Cruz 
Biotechnology N-18, used 1:100 overnight at 4°C, 
for the Western blot analysis); anti-progerin (Merck 
Millipore clone 13A4 diluted 1:10, overnight at 4°C for 
immunofluorescence analysis); anti-actin, goat polyclonal 
(Santa Cruz Biotechnology I-19, diluted 1:1000 for 1 h, 
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for the Western blot analysis);anti-trimethyl-H3K9, 
rabbit polyclonal (Upstate, used 1:100 for 1 h at room 
temperature for the immunofluorescence analysis); anti-
LAP2α, rabbit polyclonal Dechat [51] (used at 1:500 
dilution for the immunofluorescence analysis and at 
1:1000 dilution for the Western blot analysis overnight 
at 4°C); anti-HP1α, rabbit polyclonal (Upstate, used 
1:500 for 1 h, for the Western blot analysis); anti-HP1α, 
rabbit polyclonal (Abcam, used at 1:100 dilution for 
immunofluorescence analysis).
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